Yuuji Murakami

Last Updated :2026/06/03

Affiliations, Positions
Graduate School of Biomedical and Health Sciences, Professor
Self-introduction
Radiation oncologist SPECIALITY Development of new techniques in Intensity Modulated Radiation Therapy Chemoradiotherapy for cancer of the digestive system Prediction of the outcomes of radiotherapy using AI & radiomics

Basic Information

Major Professional Backgrounds

  • 1995/05/16, 1996/03/30, Hiroshima University, Medical Hospital, Clinical Resident
  • 1996/04/01, 1998/02/28, Miyoshi Central Hospital, Department of Radiology,, Doctor
  • 1998/03/01, 2002/03/31, Hiroshimma city Asa hospital, Department of Radiology, Doctor
  • 2002/04/01, 2003/03/30, Hiroshima University, Medical Hospital, Clinical Fellow
  • 2005/04/01, 2007/03/31, Hiroshima University, Hospital, Research Associate
  • 2007/04/01, 2011/03/31, Hiroshima University, Hospital, Assistant Professor
  • 2011/04/01, 2019/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Lecturer
  • 2019/04/01, 2021/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Lecturer
  • 2021/04/01, 2024/08/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Associate Professor

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical Sciences, Japan, 2003/04, 2007/05
  • Hiroshima University, Faculty of Medicine, Japan, 1988/04, 1995/03

Academic Degrees

  • M.D. Ph.D., Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Medical Physicist
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Radiation science

Research Keywords

  • Prediction of radiotherapy treatment outcomes using radiomics and AI
  • upper and lower digestive cancer
  • chemoradiotherapy
  • volumetric intensity modulated radiation therapy
  • radiotherapy
  • esophageal cancer
  • Head and neck cancer

Affiliated Academic Societies

  • Japanese society of medical oncology, 2020/05
  • American Society for Radiation Oncology

Educational Activity

Course in Charge

  1. 2026, Undergraduate Education, First Semester, Radiation Biology & Radiation Health Risk Sciences
  2. 2026, Undergraduate Education, Year, Systemic Disease Control
  3. 2026, Undergraduate Education, Intensive, Practice for medical research
  4. 2026, Undergraduate Education, Intensive, Practice of Medicine I
  5. 2026, Undergraduate Education, Intensive, Practice of Medicine II
  6. 2026, Graduate Education (Master's Program) , First Semester, Research on Radiation Oncology
  7. 2026, Graduate Education (Master's Program) , Second Semester, Research on Radiation Oncology
  8. 2026, Graduate Education (Master's Program) , First Semester, Physics of Diagnostic Radiology
  9. 2026, Graduate Education (Master's Program) , First Semester, Radiation Oncology Physics
  10. 2026, Graduate Education (Master's Program) , Second Semester, Physics of Nuclear Medicine
  11. 2026, Graduate Education (Master's Program) , First Semester, Radiation Oncology
  12. 2026, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Oncology Physics
  13. 2026, Graduate Education (Master's Program) , Second Semester, Seminar on Radiation Dosimetry
  14. 2026, Graduate Education (Master's Program) , Second Semester, Seminar on Physics of Diagnostic Imaging
  15. 2026, Graduate Education (Master's Program) , First Semester, Seminar on Physics of Nuclear Medicine
  16. 2026, Graduate Education (Master's Program) , Second Semester, Radiation Safety
  17. 2026, Graduate Education (Master's Program) , First Semester, English for Scientific Paper
  18. 2026, Graduate Education (Master's Program) , First Semester, Biostatistics
  19. 2026, Graduate Education (Master's Program) , Second Semester, Health Physics
  20. 2026, Graduate Education (Doctoral Program) , 1Term, Principles of Oncology
  21. 2026, Graduate Education (Doctoral Program) , 1Term, Practice of Oncology
  22. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  23. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology
  24. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Radiation Oncology
  25. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Radiation Oncology
  26. 2026, Graduate Education (Doctoral Program) , First Semester, Clinical Practicum in Medical Physics
  27. 2026, Graduate Education (Doctoral Program) , Second Semester, Clinical Practicum in Medical Physics
  28. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Radiation Oncology
  29. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Radiation Oncology

Research Activities

Academic Papers

  1. PNA-FISH-based Chromosome Aberration Frequency and Serum IL-6 as Predictive Biomarkers for Radiation Therapy-induced Pneumonitis in Lung Cancer Patients, RADIATION RESEARCH, 204(2), 127-142, 202508
    Link to Paper Search Results by DOI
  2. Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol, JMIR RESEARCH PROTOCOLS, 15, 2026
    Link to Paper Search Results by DOI
  3. Survival prediction in non-small cell lung cancer using layer-wise radiomics and stacked radscore integration: a multi-institutional study, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 145, 202605
    Link to Paper Search Results by DOI
  4. Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational Study, CANCERS, 18(4), 20260219
    Link to Paper Search Results by DOI
  5. A Radiomics-Based Machine Learning Model for Predicting Pneumonitis During Durvalumab Treatment in Locally Advanced NSCLC, AI, 7(1), 20260116
    Link to Paper Search Results by DOI
  6. Margin reduction and optimal prescription isodose model for liver stereotactic radiotherapy with respiratory motion, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 27(1), 20260107
    Link to Paper Search Results by DOI
  7. Prediction of radiation pneumonitis after CRT in patients with advanced NSCLC using multi-region radiomics and attention-based ensemble learning, MEDICAL PHYSICS, 52(12), 20251119
    Link to Paper Search Results by DOI
  8. Investigating tumor-infiltrating lymphocytes as predictors of lymph node metastasis in deep submucosal invasive esophageal squamous cell carcinoma: a retrospective cross-sectional study, JOURNAL OF GASTROENTEROLOGY, 60(11), 1362-1371, 202511
    Link to Paper Search Results by DOI
  9. Compensated biological effective dose in extended radiotherapy course via a time-modified linear quadratic model for biological adaptive radiotherapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 139, 202511
    Link to Paper Search Results by DOI
  10. Pioneering Change in Radiotherapy With Biological Adaptive Radiotherapy for Lung Volumetric Modulated Radiotherapy (VMAT) Patients, CLINICAL ONCOLOGY, 48, 202512
    Link to Paper Search Results by DOI
  11. Radiomics-based decision support tool with ground-glass opacity status of 5-year survival prediction for early-stage non-small cell lung cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 30(4), 502-512, 2025
    Link to Paper Search Results by DOI
  12. Association between geriatric 8 (G8) scores and self-care decline in elderly patients with head and neck squamous cell carcinoma undergoing radiotherapy, SUPPORTIVE CARE IN CANCER, 33(10), 20250916
    Link to Paper Search Results by DOI
  13. Optimisation of Margin Adaptation for Respiratory Motion in Lung Cancer Stereotactic Body Radiation Therapy Using Virtual Fourdimensional Volumetric Modulated Arc Therapy System Radiotherapy, CLINICAL ONCOLOGY, 47, 202511
    Link to Paper Search Results by DOI
  14. Biological adaptive radiotherapy for short-time dose compensation in lung SBRT patients, MEDICAL PHYSICS, 52(7), 202507
    Link to Paper Search Results by DOI
  15. Treatment outcomes and failure patterns in postoperative radiotherapy for major salivary gland carcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 55(7), 751-757, 202507
    Link to Paper Search Results by DOI
  16. Suppressive effect of vitamin K2 (menatetrenone) against bone mineral density loss after radiotherapy in uterine cancer patients, JAPANESE JOURNAL OF RADIOLOGY, 43(6), 1025-1035, 202506
    Link to Paper Search Results by DOI
  17. Elucidating the biological function of computed tomography (CT)-based radiomics biomarkers in serous ovarian cancer, CLINICAL RADIOLOGY, 86, 202507
    Link to Paper Search Results by DOI
  18. Head and neck cancer registry of Japan, AURIS NASUS LARYNX, 52(2), 122-126, 202504
    Link to Paper Search Results by DOI
  19. Multicatheter-guided rigid registration for high-dose-rate interstitial brachytherapy for mobile tongue cancer, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 133, 202505
    Link to Paper Search Results by DOI
  20. Improved stoichiometric model for megavoltage computed tomography number conversion and dose calculation within the TomoTherapy delivery system, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 132, 202504
    Link to Paper Search Results by DOI
  21. A nomogram-based survival prediction model for non-small cell lung cancer patients based on clinical risk factors and multiregion radiomics features, CLINICAL RADIOLOGY, 84, 202505
    Link to Paper Search Results by DOI
  22. Assessment of CT-to-physical density table for multiple image reconstruction functions with a large-bore scanner for radiotherapy treatment planning, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 133, 202505
    Link to Paper Search Results by DOI
  23. Integrating radiomics and gene expression by mapping on the image with improved DeepInsight for clear cell renal cell carcinoma, CANCER GENETICS, 292-293, 100-105, 202504
    Link to Paper Search Results by DOI
  24. Dose compensation for decreased biological effective dose due to intrafractional interruption during radiotherapy: integration with a commercial treatment planning system, BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 11(1), 20250131
    Link to Paper Search Results by DOI
  25. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer, EJSO, 50(7), 202407
    Link to Paper Search Results by DOI
  26. Long-term treatment results of medulloblastoma at Hiroshima University Hospital, Journal of Hiroshima Medical Association, 76(6), 228-234, 202306
  27. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model, EUROPEAN RADIOLOGY, 34(2), 1200-1209, 202402
    Link to Paper Search Results by DOI
  28. Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery, WORLD JOURNAL OF SURGERY, 48(2), 416-426, 202402
    Link to Paper Search Results by DOI
  29. Unbiased evaluation of predicted gamma passing rate by an event-mixing technique, MEDICAL PHYSICS, 51(1), 5-17, 202401
    Link to Paper Search Results by DOI
  30. Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study, BRITISH JOURNAL OF RADIOLOGY, 97(1153), 142-149, 20240123
    Link to Paper Search Results by DOI
  31. Radiation doses of medical radiation workers performing low-dose-rate brachytherapy with 198Au grains and 192Ir pins for patients with oral cancers, ORAL RADIOLOGY, 40(2), 234-241, 202404
    Link to Paper Search Results by DOI
  32. Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 116(4), 739-746, 20230715
    Link to Paper Search Results by DOI
  33. Risk factors for aortoesophageal fistula in cT4b esophageal squamous cell carcinoma after definitive radiation therapy, JOURNAL OF THORACIC DISEASE, 15(10), 5319-5329, 202310
    Link to Paper Search Results by DOI
  34. ★, Novel simulation for dosimetry impact of diaphragm respiratory motion in four-dimensional volumetric modulated arc therapy for esophageal cancer, RADIOTHERAPY AND ONCOLOGY, 187, 202310
    Link to Paper Search Results by DOI
  35. Efficacy of Supportive Care for Radiodermatitis in Patients with Head and Neck Cancer: Supplementary Analysis of an Exploratory Phase II Trial, JOURNAL OF PERSONALIZED MEDICINE, 13(9), 202309
    Link to Paper Search Results by DOI
  36. Outcome of Hypofractionated Radiotherapy for Localized Gastric Mucosa-associated Lymphoid Tissue Lymphoma, ANTICANCER RESEARCH, 43(8), 3673-3678, 202308
    Link to Paper Search Results by DOI
  37. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma, ESOPHAGUS, 20(3), 541-547, 202307
    Link to Paper Search Results by DOI
  38. Effectiveness of Spacers in Brachytherapy With 198Au Grains for Patients With Buccal Mucosa Cancer, ANTICANCER RESEARCH, 43(5), 2265-2271, 202305
    Link to Paper Search Results by DOI
  39. A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial), JOURNAL OF RADIATION RESEARCH, 64(1), 154-161, 20230120
    Link to Paper Search Results by DOI
  40. Influence of different air CT numbers for IVDT on the dose distribution in TomoTherapy MVCT, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 24(2), 202302
    Link to Paper Search Results by DOI
  41. Tolerance levels of mass density for adaptive helical tomotherapy using MVCT, JOURNAL OF RADIATION RESEARCH, 64(1), 195-201, 20230120
    Link to Paper Search Results by DOI
  42. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28(3), 382-391, 202303
    Link to Paper Search Results by DOI
  43. Robust optimization of VMAT for prostate cancer accounting for geometric uncertainty, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 23(9), 202209
    Link to Paper Search Results by DOI
  44. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy, SURGERY, 172(2), 584-592, 202208
    Link to Paper Search Results by DOI
  45. Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1), RADIATION ONCOLOGY, 17(1), 20220728
    Link to Paper Search Results by DOI
  46. A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning, BRITISH JOURNAL OF RADIOLOGY, 95(1135), 202207
    Link to Paper Search Results by DOI
  47. Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer, ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 134(1), 93-101, 202207
    Link to Paper Search Results by DOI
  48. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42(5), 2791-2795, 202205
    Link to Paper Search Results by DOI
  49. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, RADIOTHERAPY AND ONCOLOGY, 166, 65-70, 202201
    Link to Paper Search Results by DOI
  50. Investigating the displacement of radio-active sources during gold-198 grain brachytherapy for hospitalized oral cancer patients, JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 14(2), 115-122, 20220323
    Link to Paper Search Results by DOI
  51. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma, ADVANCES IN RADIATION ONCOLOGY, 2(2), 183-191, 2017
    Link to Paper Search Results by DOI
  52. Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review, JOURNAL OF GASTROINTESTINAL ONCOLOGY, 13(2), 885-897, 202204
    Link to Paper Search Results by DOI
  53. Baseline drift vector of multiple points on body surface using a near-infrared camera, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 45(1), 143-155, 202203
    Link to Paper Search Results by DOI
  54. Brachytherapy with Au-198 grains for cancer of the floor of the mouth: relationships between radiation dose and complications, ORAL RADIOLOGY, 38(1), 105-113, 202201
    Link to Paper Search Results by DOI
  55. Reirradiation Using Au-198 Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy, ANTICANCER RESEARCH, 42(1), 293-300, 202201
    Link to Paper Search Results by DOI
  56. Temporal changes and risk factors for esophageal stenosis after salvage radiotherapy in superficial esophageal cancer following non-curative endoscopic submucosal dissection, Radiotherapy and Oncology, 166, 65-70, 20211125
  57. A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor, International Journal of Radiation Oncology*Biology*Physics, 111(3), 20211101
  58. Treatment outcomes of real-time intraoral sonography-guided implantation technique of Au-198 grain brachytherapy for T1 and T2 tongue cancer, JOURNAL OF RADIATION RESEARCH, 62(5), 871-876, 202109
    Link to Paper Search Results by DOI
  59. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning, BRITISH JOURNAL OF RADIOLOGY, 94(1124), 20210708
    Link to Paper Search Results by DOI
  60. Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer, LARYNGOSCOPE, 131(7), 1522-1527, 20210701
    Link to Paper Search Results by DOI
  61. ★, Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using F-18-FDG PET Images, DIAGNOSTICS, 11(6), 20210601
    Link to Paper Search Results by DOI
  62. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28(3), 1798-1807, 20210301
    Link to Paper Search Results by DOI
  63. Evaluating Individual Radiosensitivity for the Prediction of Acute Toxicities of Chemoradiotherapy in Esophageal Cancer Patients, RADIATION RESEARCH, 195(3), 244-252, 20210301
    Link to Paper Search Results by DOI
  64. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer, JOURNAL OF RADIATION RESEARCH, 62(2), 300-308, 20210301
    Link to Paper Search Results by DOI
  65. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62(1), 142-148, 20210101
    Link to Paper Search Results by DOI
  66. Evaluation of optimization workflow using custom-made planning through predicted dose distribution for head and neck tumor treatment, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 80, 167-174, 20201201
    Link to Paper Search Results by DOI
  67. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27(11), 4422-4430, 20201001
    Link to Paper Search Results by DOI
  68. What motivated medical students and residents to become radiation oncologists in Japan?-Questionnaire report by the radiotherapy promotion committee of JASTRO, JOURNAL OF RADIATION RESEARCH, 61(5), 727-732, 20200901
    Link to Paper Search Results by DOI
  69. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(7), 1250-1259, 20200701
    Link to Paper Search Results by DOI
  70. A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers, ANTICANCER RESEARCH, 40(7), 4183-4190, 20200701
    Link to Paper Search Results by DOI
  71. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents, JOURNAL OF RADIATION RESEARCH, 61(4), 629-634, 20200701
    Link to Paper Search Results by DOI
  72. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers, JOURNAL OF RADIATION RESEARCH, 61(4), 554-562, 20200701
    Link to Paper Search Results by DOI
  73. Effectiveness of salvage radiotherapy for superficial esophageal Cancer after non-curative endoscopic resection, RADIATION ONCOLOGY, 15(1), 20200601
    Link to Paper Search Results by DOI
  74. Evaluation of metal artefact techniques with same contrast scale for different commercially available dual-energy computed tomography scanners, PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 43(2), 539-546, 20200601
    Link to Paper Search Results by DOI
  75. An overview of stereotactic body radiation therapy for hepatocellular carcinoma, EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 14(4), 271-279, 20200402
    Link to Paper Search Results by DOI
  76. Predictive gamma passing rate for three-dimensional dose verification with finite detector elements via improved dose uncertainty potential accumulation model, MEDICAL PHYSICS, 47(3), 1349-1356, 20200301
    Link to Paper Search Results by DOI
  77. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram, JOURNAL OF RADIATION RESEARCH, 61(2), 298-306, 20200301
    Link to Paper Search Results by DOI
  78. Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?, ANTICANCER RESEARCH, 39(8), 4279-4283, 201908
    Link to Paper Search Results by DOI
  79. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
    Link to Paper Search Results by DOI
  80. Photon and electron backscatter dose and energy spectrum analysis around Lipiodol using flattened and unflattened beams, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 20(6), 178-183, 201906
    Link to Paper Search Results by DOI
  81. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
    Link to Paper Search Results by DOI
  82. Automatic calibration of an arbitrarily-set near-infrared camera for patient surface respiratory monitoring, MEDICAL PHYSICS, 46(3), 1163-1174, 201903
    Link to Paper Search Results by DOI
  83. Predictive gamma passing rate by dose uncertainty potential accumulation model, MEDICAL PHYSICS, 46(2), 999-1005, 201902
    Link to Paper Search Results by DOI
  84. A novel risk analysis of clinical reference dosimetry based on failure modes and effects analysis, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 58, 59-65, 201902
    Link to Paper Search Results by DOI
  85. Development of geometrically ideal dose distribution as a reference for treatment planning in VMAT using filtered back-projection method, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 57, 115-122, 20190101
    Link to Paper Search Results by DOI
  86. Evaluation of raw-data-based and calculated electron density for contrast media with a dual-energy CT technique, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 24(5), 499-506, 2019
    Link to Paper Search Results by DOI
  87. Medium-term results of intensity modulated radiation therapy for patients with T1-3N0M0 prostate cancer, The journal of the Hiroshima medical association, 71(10), 663-668, 20181028
  88. Evaluation of optimization workflow using design of experiment (DoE) for various field configurations in volumetric-modulated arc therapy, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 54, 34-41, 201810
    Link to Paper Search Results by DOI
  89. Clinical features of prostate-specific antigen bounce after I-125 brachytherapy for prostate cancer, JOURNAL OF RADIATION RESEARCH, 59(5), 649-655, 201809
    Link to Paper Search Results by DOI
  90. Long-term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma, HEPATOLOGY RESEARCH, 48(9), 701-707, 201808
    Link to Paper Search Results by DOI
  91. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17, 20180701
    Link to Paper Search Results by DOI
  92. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, 201807
    Link to Paper Search Results by DOI
  93. Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer, PLOS ONE, 13(6), 20180611
    Link to Paper Search Results by DOI
  94. Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas, DIGESTIVE DISEASES AND SCIENCES, 63(6), 1605-1612, 201806
    Link to Paper Search Results by DOI
  95. ★, Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, Journal of Radiation Research, 59(5), 616-624, 201806
  96. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, World Journal of Surgery, 5(42), 1496-1505, 201806
  97. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, 201805
    Link to Paper Search Results by DOI
  98. Effect of secondary electron generation on dose enhancement in Lipiodol with and without a flattening filter, JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 19(2), 211-217, 201803
    Link to Paper Search Results by DOI
  99. Relative biological effectiveness study of Lipiodol based on microdosimetric-kinetic model, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 46, 89-95, 201802
    Link to Paper Search Results by DOI
  100. Energy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(1), 50-56, 2018
    Link to Paper Search Results by DOI
  101. Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 23(2), 84-90, 2018
    Link to Paper Search Results by DOI
  102. Automatic contrast medium extraction system using electron density data with dual-energy CT, BRITISH JOURNAL OF RADIOLOGY, 91(1090), 2018
    Link to Paper Search Results by DOI
  103. Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma, JAPANESE JOURNAL OF RADIOLOGY, 35(11), 673-680, 201711
    Link to Paper Search Results by DOI
  104. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer, ANTICANCER RESEARCH, 37(5), 2709-2713, 201705
    Link to Paper Search Results by DOI
  105. Evaluation of beam modeling for small fields using a flattening filter-free beam, RADIOLOGICAL PHYSICS AND TECHNOLOGY, 10(1), 33-40, 201703
    Link to Paper Search Results by DOI
  106. Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma., Adv Radiat Oncol, 2(2), 183-191, 201702
  107. Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408), JOURNAL OF RADIATION RESEARCH, 58(1), 149-154, 201701
    Link to Paper Search Results by DOI
  108. Dosimetric impact of Lipiodol in stereotactic body radiation therapy on liver after trans-arterial chemoembolization, MEDICAL PHYSICS, 44(1), 342-348, 201701
    Link to Paper Search Results by DOI
  109. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma, MEDICAL DOSIMETRY, 42(2), 97-103, 2017
    Link to Paper Search Results by DOI
  110. Absorbed dose and image quality of Varian TrueBeam CBCT compared with OBI CBCT, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(12), 1628-1633, 201612
    Link to Paper Search Results by DOI
  111. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34(9), 595-604, 201609
    Link to Paper Search Results by DOI
  112. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors, PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 32(4), 557-561, 201604
    Link to Paper Search Results by DOI
  113. Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21(1), 88-94, 201602
    Link to Paper Search Results by DOI
  114. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, RADIOTHERAPY AND ONCOLOGY, 118(1), 60-64, 201601
    Link to Paper Search Results by DOI
  115. Preoperative coil embolization in patients with a replaced hepatic artery scheduled for pancreatectomy with splanchnic artery resection helps to prevent ischemic organ injury., Journal of Computer Assisted Tomography, 40(1), 172-176, 201601
  116. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29(8), 1115-1120, 2016
    Link to Paper Search Results by DOI
  117. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients` exposure dose, Reports of Practical Oncology & Radiotherapy, 21(5), 460-465, 2016
    Link to Paper Search Results by DOI
  118. Impact of reduction of flux overlap region on kilovoltage cone-beam computed tomography image quality and patients' exposure dose, REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 21(5), 460-465, 2016
    Link to Paper Search Results by DOI
  119. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(4), 778-787, 20151115
    Link to Paper Search Results by DOI
  120. ★, Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20(5), 897-904, 201510
    Link to Paper Search Results by DOI
  121. The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma, PLOS ONE, 10(6), 20150611
    Link to Paper Search Results by DOI
  122. Results of sequential chemoradiotherapy for intracranial germinoma, JAPANESE JOURNAL OF RADIOLOGY, 33(6), 336-343, 201506
    Link to Paper Search Results by DOI
  123. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, 201506
    Link to Paper Search Results by DOI
  124. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies, HEPATOLOGY RESEARCH, 45(4), 378-386, 201504
    Link to Paper Search Results by DOI
  125. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy, JOURNAL OF RADIATION RESEARCH, 56(2), 315-324, 201503
    Link to Paper Search Results by DOI
  126. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma, HEPATOLOGY RESEARCH, 44(10), E273-E278, 201410
    Link to Paper Search Results by DOI
  127. Time-Adjusted Internal Target Volume: A Novel Approach Focusing on Heterogeneity of Tumor Motion Based on 4-Dimensional Computed Tomography Imaging for Radiation Therapy Planning of Lung Cancer, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 89(5), 1129-1137, 20140801
    Link to Paper Search Results by DOI
  128. Radiation-induced pyogenic vertebral osteomyelitis after re-irradiation for para-aortic lymph node metastases in a patient with cervical cancer, International Cancer Conference Journal, 3(4), 207-210, 2014
  129. Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?, HEPATOLOGY RESEARCH, 43(7), 717-727, 201307
    Link to Paper Search Results by DOI
  130. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69(6), 1499-1505, 201206
    Link to Paper Search Results by DOI
  131. ★, Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(3), 263-271, 201206
    Link to Paper Search Results by DOI
  132. Functional Image-Guided Radiotherapy Planning in Respiratory-Gated Intensity-Modulated Radiotherapy for Lung Cancer Patients With Chronic Obstructive Pulmonary Disease, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E663-E670, 20120315
    Link to Paper Search Results by DOI
  133. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17(1), 48-54, 201202
    Link to Paper Search Results by DOI
  134. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer., Hiroshima Journal of Medical Science, 60(4), 51-56, 20111201
  135. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Radiother Oncol., 118(1), 60-64, 2010
  136. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix., Int J Radiat Oncol Biol Phys, 75(2), 369-377, 20091001
  137. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001., Int J Radiat Oncol Biol Phys., 75(2), 357-363, 20091001
  138. Results of a preliminary study using hypofractionated involved field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced Non-Small-Cell lung cancer, Int J Clin Oncol,, 14(5), 408-415, 20091001
  139. Results of the 1999-2001 Japanese Patterns of Care Study for Patients Receiving Defintive Radiation Theraphy without Surgery for Esophageal Cancer, Japanese journal of clinical oncology, 37(7), 493-500, 20070723
  140. ★, Evaluation of the basic properties of the BANGkitTM gel dosimeter, Physics in Medicine and Biology, 52(8), 2301-2311, 20070403
    Link to Paper Search Results by DOI
  141. ★, Evaluation of the basic properties of the BANGkit? gel dosimeter, Physics in Medicine and Biology= Institute of Physics, 52, 2301-2311, 20070403
  142. Preoperative portal vein embolization with a mixture of gelatin sponge and lodized oil: Efficacy and safety, Acta Radiologica, 47(10), 1022-1028, 20061201
  143. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?, International radiation oncology biology and physics, 66(2), 483-491, 20061001
  144. Diffuse cerebral white matter T2-weighted hyperintensity: a new finding of general paresis., Acta Radiologica, 47, 609-611, 20060701
  145. Potential benefits of volumetric modulated arc therapy to reduce the incidence of >= grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(12), 1729-1735, 202112
    Link to Paper Search Results by DOI

Publications such as books

  1. 2020/09, Guideline for radiotherapy treatment planning, 2020, September, Textbook, Joint work, 日本語, ISBN: 9784307071161, 440, 139-144
    Amazon URL
  2. 2016/09/15, Guideline for radiotherapy treatment planning, 2016, September, Textbook, Joint work, 日本語, 978-4-307-07104-8, 408, 119-123
    Amazon URL

Invited Lecture, Oral Presentation, Poster Presentation

  1. Introducing SBRT and hypofractionated 3DCRT for liver cancer in Mongolia., Tsegmed U, Batsuuri B, Magsar B, Bayasgalan U, Unenbat U, Nasanbayar G, Byambajav A, Gonchig O, Minjgee M, Imano N, Murakami Y, Kawahara D, Okumura T, Nagata Y, The 7th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2025/11/13, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), Chang Mai, Thailand
  2. Cardiopulmonary dosimetry and safety of VMAT in locally advanced thoracic and EGJ cancer., Katsuta T, Ymamamoto Y, Tani S, Sadatoki T, Miyoshi S, Imano N, Nishibuchi I, Murakami Y, The 7th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2025/11/13, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), Chang Mai, Thailand
  3. Modeling RT-Induced immune priming to optimize immunotherapy timing in radiotherapy., Kawahara D, Kishi M, Murakami Y, Watanabe Y, American Society for Radiology Oncology 67th Annual Meeting (ASTRO 2025), 2025/09/27, Without Invitation, English, American Society for Radiology Oncology, San Francisco, USA
  4. The impact of tumor-induced nutritional disorders on the relationship between G8 scores and definitive radiotherapy strategies., Nishibuchi I, Tani S, Katsuta T, Imano N, Murakami Y, American Society for Radiology Oncology 67th Annual Meeting (ASTRO 2025), 2025/09/27, Without Invitation, English, American Society for Radiology Oncology, San Francisco, USA
  5. Chromosomal aberrations in peripheral blood lymphocytes as predictive biomarkers for severe adverse events in thoracic definitive chemoradiotherapy., Imano N, Nishibuchi I, Loy-Caraos G, Sun J, Katsuta T, Murakami Y, Tashiro S, American Society for Radiology Oncology 67th Annual Meeting (ASTRO 2025), 2025/09/27, Without Invitation, English, American Society for Radiology Oncology, San Francisco, USA
  6. AI and radiotherapy (JASTRO), Murakami Y, The 10th Annual Taiwan-Japan Radiation Oncology Symposium(The 10th TJROS) & The 4th International Summit of Taiwan's Particle Therapy (ISTPT 2025) and 2025 Annual Scientific Meeting of CSMPT(2025 CSMPT), 2025/08/30, With Invitation, English, Kaohsiung City, Taiwan
  7. Exploring NSCLC microenvironments: Multi-score survival models integrationg radiomics-based regional imaging features and genomics., Kishi M, Kawahara D, Imano N, Murkami Y., The 67th American Association of Physicists in Medicine Annual Meeting & Exhibition, 2025/07/27, Without Invitation, English, American Association of Physicists in Medicine, Washington, DC, America
  8. Real-time fully automated IMRT planning without optimization process using a two-step AI framework., Yanagida R, Kawahara D, Matsuura T, Murakami Y., The 67th American Association of Physicists in Medicine Annual Meeting & Exhibition, 2025/07/27, Without Invitation, English, American Association of Physicists in Medicine, Washington, DC, America
  9. Tailor-TS system: Tailored tumor segmentation system with facility-specific semi-supervised learning., Kawahara D, Yang D, Hao V G, Xu D, Kawazoe J, Nishibuchi I, Murakami Y., The 67th American Association of Physicists in Medicine Annual Meeting & Exhibition, 2025/07/27, Without Invitation, English, American Association of Physicists in Medicine, Washington, DC, America
  10. Contrastive learning and hybrid CNN-Transformer model for unpaired MR image synthesis in acute cerebral infarction., Kawazoe J, Kawahara D, Hirose K, Murakami Y., The 67th American Association of Physicists in Medicine Annual Meeting & Exhibition, 2025/07/27, Without Invitation, English, American Association of Physicists in Medicine, Washington, DC, America
  11. AI-Driven drug discovery through an interactive analysis of radiomics and biological insights in glioblastoma., Kadooka Y, Kawahara D, Kishi M, Onishi S, Imano N, Murakami Y., The 67th American Association of Physicists in Medicine Annual Meeting & Exhibition, 2025/07/27, Without Invitation, English, American Association of Physicists in Medicine, Washington, DC, America
  12. Innovative biological adaptive radiotherapy (BART) approach for head-and-neck cancer treatment interruptions., Wada T, Kawahara D, Koganezawa A, Imano N, Nishibuchi I, Murakami Y., The 67th American Association of Physicists in Medicine Annual Meeting & Exhibition, 2025/07/27, Without Invitation, English, American Association of Physicists in Medicine, Washington, DC, America
  13. Interpretation of survival predictors by CT-based radiogenomics for serous ovarian cancer., Kishi M, Kawahara D, Koh I, Tomono K, Nishibuchi I, Murakami Y, The 4th International Conference on Radiological Physics and Technology, 2025/04/10, Without Invitation, English, Yokohama, Japan
  14. TAILOR-TS system: tailored tumor segmentation system with facility-specific semi-supervised learning., Kawahara D,, Yang D, Ruan P, Xu D, Hao G, Kawazoe J, Murakami Y, The 4th International Conference on Radiological Physics and Technology, 2025/04/10, Without Invitation, English, Yokohama, Japan
  15. Development of a high-precision medical image synthesis model using transformer-enhanced patch-based contrastive learning applicable to unpaired images., Kawazoe J, Kawahara D, Hirose K, Murakami Y, 2025/04/10, Without Invitation, Japanese
  16. A novel bias-harmonized and interpretable radiomics-based prognostic prediction model for head and neck cancer patients., Aoki S, Kawahara D, Oka H, Kishi M, Kadooka Y, Murakami Y, 2025/04/10, Without Invitation, Japanese
  17. Exploring the hidden risk of contrast agent-induced radiation dose amplification in SECT and DECT., Arisawa H, Kawahara D, Nakano H, Imano N, Murakami Y, 2025/04/10, Without Invitation, Japanese
  18. Laryngo-esophageal dysfunction-free survival of chemoradiotherapy for cervical esophageal cancer, Yuji Murakami, Shota Miyoshi, Tsuyoshi Katsuta, Junichi Hirokawam, Nobuki Imano, Ikuno Nishibuchi, Yasushi Nagata, Joint FARO-ESTRO Congress @ ESTRO meets Asia 2024, 2024/08/24, Without Invitation, English, ESTRO, FARO, Kuala Lumpur, Malaysia
  19. AI-based outcome prediction for ovarian cancer using data imbalance correction method., Kishi M, Kawahara D, Oka H, Nishioka R, Saito A, Koh I, Tomono K, Nishibuchi I, Murakami Y, Nagata Y, 2023/04/13, Without Invitation, English
  20. Auto segmentation of head and neck region by generative adversarial network using multi-attention mechanism., Nishimura T, Kawahara D, Saito A, Nishibuchi I, Murakami Y, Nagata Y, 2023/04/13, Without Invitation, English
  21. Development of new contrast-enhanced radiotherapy(LiPERT)., Kawahara D, Ozawa S, Saito A, Murakami Y, Nagata Y, 2023/04/13, Without Invitation, English
  22. Assessment of the reduction in biological dose resulting from interruption of radiotherapy., Takashita N, Kawahara D, Horiuchi S, Imano N, Nishibuchi I, Murakami Y, Ozawa S, Nagata Y, 2023/04/13, Without Invitation, English
  23. Radiomics analysis machine learning for non-small cell lung cancer patients to predict recurrence after surgery., Isobe R, Kawahara D, Oka H, Nishioka R, Saito A, Imano N, Nishibuchi I, Murakami Y, Nagata Y, 2023/04/13, Without Invitation, English
  24. DAtGAN: Multi-modality brain tumor segmentation using dual-attention GAN, Kawahara D, Nishimura T, Saito A, Murakami Y, FARO2023(The 6th Meeting of the Federation of Asian Organizations for Radiation Oncology), 2023/10/12, Without Invitation, English, Federation of Asian Organizations for Radiation Oncology, Seoul, Korea
  25. The Geriatric8 Screening tool predicts declining self-care ability in elderly patients with head and neck cancer during radiotherapy, Katsuta T, Fujioka M, Imano N, Hirokawa J, Nishibuchi I, Murakami Y, Nagata Y:, FARO2023(The 6th Meeting of the Federation of Asian Organizations for Radiation Oncology), 2023/10/12, Without Invitation, English, Federation of Asian Organizations for Radiation Oncology, Seoul, Korea
  26. Impact of the G8 score on treatment strategies and outcome in definitive radiotherapy for the elderly esophageal cancer patients, Nishibuchi I, Murakami Y, Miyoshi S, Katsuta T, Imano N, Hirokawa J, Nagata Y., ASTRO 2023 (American Society for Therapeutic Radiology and Oncology 65th the Annual Meeting), 2023/10/03, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Diego, USA
  27. Predictive modeling of radiation pneumonitis induced by chemoradiotherapy for locally advanced non-small cell lung cancer using radiomics and clinical features., Imano N, Kawahara D, Nishioka R, Koike K, Katsuta T, Hirokawa J, Saito A, Nishibuchi I, Murakami Y, Nagata Y., ASTRO 2023 (American Society for Therapeutic Radiology and Oncology 65th the Annual Meeting), 2023/10/03, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Diego, USA
  28. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival for esophageal squamous cell cancer: Multi-Institutional study, Kawahara D, Nishioka R, Murakami Y, Emoto Y, Iwashita K, Kubota H, Sasaki R, Nagata Y., ASTRO 2023 (American Society for Therapeutic Radiology and Oncology 65th the Annual Meeting), 2023/10/03, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Diego, USA
  29. Laryngo-esophageal dysfunction free survival of chemoradiation for cervical esophageal cancer, Murakami Y, Miyoshi S, Katsuta T, Hirokawa J, Imano N, Nishibuchi I, Nagata Y., ASTRO 2023 (American Society for Therapeutic Radiology and Oncology 65th the Annual Meeting), 2023/10/03, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Diego, USA
  30. Cellular automata simulation study on the roles of HIF-1 alpha in the immune response of the tumor to a single high radiation dose., Kawahara D, Murakami Y, Watanabe Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  31. A comprehensive radiogenomics approach for risk assessment of overall survival in clear cell renal cell carcinoma., Nishioka R, Kawahara D, Ikeda K, Saito A, Murakami Y, Murakami Y, Nagata Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  32. Radiomics-based prediction of recurrence for head and neck cancer patients using data imbalanced correction., Oka H, Kawahara D, Saito A, Murakami Y, Nagata Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  33. Radiomics-based decision support tool with GGO status of 5-year survival prediction for early-stage non-small cell lung cancer, Isobe R, Kawahara D, Nishioka R, Imano N, Nishibuchi I, Murakami Y, Nagata Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  34. CT-based machine learning for prediction of residual tumor in ovarian cancer after surgery by data imbalance correction method, Kishi M, Kawahara D, Oka H, Nishioka R, Koh I, Tomono K, Nishibuchi I, Murakami Y, Nagata Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  35. Madc-Gan: Auto segmentation of head and neck region by generative adversarial network with dilated convolution and multi attention mechanism., Nishimura T, Kawahara D, Saito A, Nishibuchi I, Murakami Y, Nagata Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  36. Development of stoichiometric CT number calibration model for MVCTNumber to mass density, Tsunemine S, Ozawa S, Miura H, Onishi T, Inoue T, Oki Y, Harada H, Murakami Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  37. Evaluation of reduced biological effective dose due to extended treatment course period, Takashita N, Saito A, Horinouchi S, Imano N, Nishibuchi I, Murakami Y, Ozawa S, Nagata Y, AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  38. Treatment planning evaluation for total skin irradiation using helical tomotherapy, Ichiki M, Ozawa S, Makino T, Takayama D, Uchiyama N, Nishida H, Yonakura K, Murakami Y, Dokiya T, AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  39. A promising new targeted radiotherapy: Lipiodol-enhanced radiotherapy (LiPERT) for liver cancer patients., Kawahara D, Saito A, Ozawa S, Nishibuchi I, Murakami Y, Nagata Y., AAPM 2023(American Association of Physicists in Medicine 65th annual meeting & exhibition), 2023/07/24, Without Invitation, English, American Association of Physicists in Medicine, Houston, USA
  40. IMRT for H & N 1, Murakami Y, HICARE/IAEA International Training Course on Advanced Radiation Therapy for Head and Neck,Lung, and Liver Cancer, 2022/11/14, With Invitation, English, HICARE/IAEA, Hiroshima, Japan (HIPRAC)
  41. Novel simulation for dosimetry impact of diaphragm respiratory motion in 4D VMAT for esophageal cancer., Katsuta T, Kawahara D, Murakami Y, Miyoshi S, Imano N, Kubo K, Nishibuchi I, Nagata Y, ASTRO 2022(American Society for Therapeutic Radiology and Oncology 64th the Annual Meeting), 2022/10/23, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Hybrid(WEB + San Antonio, USA)
  42. Usefulness of the G8 screening tool in determining treatment strategies for definitive radiotherapy of esophageal cancer in the elderly., Nishibuchi I, Murakami Y, Miyoshi S, Katsuta T, Imano N, Nagata Y, ASTRO 2022(American Society for Therapeutic Radiology and Oncology 64th the Annual Meeting), 2022/10/23, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Hybrid(WEB + San Antonio, USA)
  43. Pain response rates after conventional radiation therapy for bone metastases assessed using international consensus pain response endpoints: A systematic review and meta-analysis of initial radiation therapy and re-irradiation., Imano N, Saito T, Nakamura N, Ito K, Yorozu A, Nishibuchi I, Murakami Y, Nagata Y, ASTRO 2022(American Society for Therapeutic Radiology and Oncology 64th the Annual Meeting), 2022/10/23, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, Hybrid(WEB + San Antonio, USA)
  44. Oral Session 2 Head and Neck, Yuji Murakami, JSMO2022, 2022/02/17, With Invitation, English
  45. Potential benefits of volumetric modulated arc therapy to reduce the incidence of grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients., Imano N, Kimura T, Kawahara D, Kubo K, Takeuchi Y, Saito A, Nishibuchi I, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  46. Survey of IMRT in Japan., Nagata Y, Ozawa S, Kawahara D, Miura H, Nakao M, Murakami Y, Nishibuchi I, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  47. Interstitial brachytherapy for locally advanced tongue cancer: Analysis of the long-term Treatment results for survival and complications., Takeuchi Y, Imano N, Nishibuchi I, Kubo K, Murakami Y, Saito A, Kawahara D, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  48. A prediction model for para-aortic lymph node metastasis in cervical cancer by radiomics analysis using pre-treatment MRI images of the primary tumor., Nishibuchi I, Kawahara d, Kawamura M, Kubo K, Imano N, Takeuchi Y, Saito A, Murakami Y, Nagata Y, ASTRO 2021(American Society for Therapeutic Radiology and Oncology 63rd the Annual Meeting), 2021/10/24, Without Invitation, English
  49. Tolerances of CT number to mass density table for adaptive helical tomotherapy with MVCT, Tsunemine S, Ozawa S, Nakao M, Miura H, Saito A, Kawahara D, Onishi Y, Onishi T, Okawa F, Terai A, Ueda R, Hashiguchi T, Enomoto N, Yamasaki H, Maruta T, Murakami Y, Nagata Y, The 9th Korea-Japan Joint Meeting on Medical, 2021/09/09, Without Invitation, English
  50. Current update and perspective of the combination of immunotherapy and radiotherapy, Yuji Murakami, JSMO2022, Without Invitation, English
  51. Association between acute toxicities of chemoradiotherapy and chromosomal aberrations in peripheral blood lymphocytes in esophageal cancer patients, Imano N, Nishibuchi I, Kawabata E, Kinugasa Y, Sakai C, Ishida M, Akita T, Kimura T, Murakami Y, Nagata Y, Tashiro S, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English
  52. Survey of stereotactic body radiation therapy in Japan, Nagata Y, Ozawa S, Nakao M, Kawahara D, Kimura T, Murakami Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English
  53. Temporal change and risk factor of esophageal stenosis after salvage radiotherapy for superficial esophageal cancer with non-curative endoscopic submucosal dissection, Murakami Y, Kawahara D, Imano N, Takahashi I, Takeuchi Y, Nishibuchi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  54. A machine learning model with radiomics based on PET images to predict pathological response by neoadjuvant chemoradiotherapy for esophageal cancer., Murakami Y, Kawahara D, Imano N, Takahashi I, Takeuchi Y, Nishibuchi I, Kimura T, Nagata Y, ASTRO 2020 (American Society for Therapeutic Radiology and Oncology 62nd the Annual Meeting), 2020/10/24, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, WEB
  55. Aperture area in IMRT studied via accumulated dose uncertainty potential, Shiba E, Saito A, Furumi M, Kawahara D, Miki K, Murakami Y, Ohguri T, Ozawa S, Tsuneda M, Yahara K, Nishio T, Korogi Y, Nagata Y, AAPM 2020(American Association of Physicists in Medicine 62nd annual meeting & exhibition), 2020/07/12, Without Invitation, English, (American Association of Physicists in Medicine
  56. Novel index to predict non-hematologic acute toxicities caused by chemoradiotherapy in esophageal cancer patients., Imano N, Nishibuchi I, Kameoka T, Ochi M, Takeuchi Y, Takahashi I, Kimura T, Murakami Y, Tashiro S, Nagata Y, 2020/05/15, Without Invitation, Japanese
  57. A new work-flow of appropriate planning for VMAT using patient specific template with geometrical ideal dose distribution., Miki K, Saito A, Kawahara D, Nakashima T, Nishibuchi I, Kimura T, Murakami Y, Nagata Y:, 2020/05/15, Without Invitation, Japanese
  58. Association between Severe Gastrointestinal Toxicity and Molecular Targeted Therapy in Patients Received Radiotherapy for Metastatic Bone Tumor or Myeloma., Murakami Y 1, Ishikawa K 2, Sakayauchi T 3, Itasaka S 4, Negoro Y 5, Jingu K 6, Nishimura Y2 , Nagata Y 1, Ogawa K 7., 61st Annual meeting of American society of radiation oncology, 2019/09/16, Without Invitation, English
  59. Current Status of Radiotherapy for Esophageal Squamous Cell Carcinoma In Japan, Yuji Murakami, 2019 Health Science Symposium with Taichung Veterans General Hospital, 2019/07/26, Without Invitation, English, Hiroshima University Hospital, Hiroshima
  60. IMRT for prostate, Murakami Y, HICARE/IAEA International Training Course on Advanced Radiation Therapy (IAEA-RCA Regional Training Course), 2019/02/18, Without Invitation, English, HICARE/IAEA
  61. A Simplified Three-Isocenter VMAT for Craniospinal Irradiation, Takahashi I, Adachi Y, Imano N, Takeuchi Y, Nishibuchi I, Miki K, Saito, A , Kimura T, Murakami Y, Nagata Y, European Society for Radiotherapy and Oncology meets Asia 2018(ESTRO), 2018/12/07, Without Invitation, English, European Society for Radiotherapy and Oncology, Singapore
  62. A simplified three-isocenter VMAT for craniospinal irradiation., Takahashi I, Imano N, Takeuchi Y, Nishibuchi I, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  63. Comparison of stereotactic body radiation therapy combined with or without transcatheter arterial chemoembolization for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies., Kimura T, Doi Y, Aikata H, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Katsuta T, Kenjo K, Murakami Y, Awai K, Chayama K, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  64. The efficacy and tolerability of S-1 in the treatment of preoperative chemoradiotherapy for locally advanced rectal cancer., Imano N, Nishibuchi I, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Murakami Y, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  65. Salvage radiation therapy with elective nodal irradiation for superficial esophageal cancer after incomplete endoscopic resection., Nishibuchi I, Murakami Y, Imano N, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., ASTRO 2018 (American Society for Therapeutic Radiology and Oncology 60th the Annual Meeting), 2018/10/21, Without Invitation, English, American Society for Therapeutic Radiology and Oncology, San Antonio, America
  66. Long-Term Results of Neoadjuvant Chemoradiotherapy + Esophagectomy for Resectable Locally Advanced Esophageal Cancer, Yuji Murakami, 2018/10/13, Without Invitation, Japanese, JASTRO, Kyoto
  67. Current Status of Radiotherapy for Esophageal Cancer, Yuji Murakami, The National Radiation Oncology Meeting on Advanced Radiation Oncology Technologies in Mongolia, 2018/09/18, With Invitation, English, National cancer center Mongolia, Ulaanbaatar, Mongolia
  68. The Efficacy and Tolerability of S-1 in the Treatment of Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer., Imano N, Murakami Y, Nishibuchi I, Adachi Y, Takeuchi Y, Takahashi I, Kimura T, Nagata Y., The 3rd Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2018/09/06, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), Bali, Indonesia
  69. Biological dose enhancement using lipiodol in liver SBRT after TACE., Kawahara D, Nakano H, Ozawa S, Saito A, Kimura T, Tsuneda M, Hioki K, Masuda H, Ochi Y, Nakashima T, Ohno Y, Murakami Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  70. Structure and aperture-based robustness estimation for volumetric modulated arc therapy., Mori M, Saito A, Kawahara D, Miki K, Murakami Y, Nakashima T, Okumura T, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  71. Predictive gamma passing rate based on dose uncertainty for head-and-neck and prostate IMRT., Shiba E, Saito A, Tsuneda M, Furumi M, Yahara K, Ohguri T, Murakami Y, Nishio T, Korogi Y, Nagata Y., AAPM 2018(American Association of Physicists in Medicine 60th annual meeting & exhibition), 2018/07/29, Without Invitation, English, American Association of Physicists in Medicine, Nashville TN, America
  72. Tips & Pitfall in H&N VMAT, Yuji Murakami, 2018/06/02, With Invitation, Japanese, Shizuoka Japan
  73. Simulation study of volumetric modulated arc therapy for thoracic esophageal cancer using automated-radiotherapy planning software., Yuji Murakami, Yasushi Nagata, Tomoki Kimura, Ikuno Nishibuchi, Takeo Nakashima;, Gastrointestinal Cancers Symposium 2018, 2018/01/19, Without Invitation, English, American society of clinical oncology, San Francisco USA
  74. Current status of radiotherapy for brain metastasis, Yuji Murakami, Hiroshima Gamma Knife Conference, 2018/01/10, With Invitation, Japanese
  75. Current status and future perspective of IMRT in Hiroshimauniversity hospital, Yuji Murakami, Hiroshima university hospital oncology meeting, 2018/01/10, Without Invitation, Japanese
  76. Long-term results of definitive chemoradiotherapy for elderly patients with esophageal cancer, Nishibuchi I, Murakami Y, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Wadasaki K, Nagata Y, Proceedings of the American Society for Radiation Oncology 59th annual meeting (ASTRO), 2017/09/25, Without Invitation, English, the American Society for Radiation Oncology, San Diego, USA
  77. Long-term results of stereotactic body radiation therapy for patients with small hepatocellular carcinoma inligible for resection or ablation therapies., Kubo K, Kimura T, Aikata H, Takahashi S, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Chayama K, Nagata Y, Proceedings of the American Society for Radiation Oncology 59th annual meeting, 2017/09/25, Without Invitation, English, the American Society for Radiation Oncology 59th annual meeting, San Diego USA
  78. Repeated stereotactic body radiotherapy for intra-hepatic recurrent hepatocellular carcinoma., Kimura T, Hioki K, Aikata H, Kubo K, Takahashi S, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Chayama K, Nagata Y, Proceedings of the American Society for Radiation Oncology 59th annual meeting, 2017/09/25, Without Invitation, English, the American Society for Radiation Oncology 59th annual meeting, San Diego USA
  79. Educational Lecture 1 Head & Neck cancer, 2017/09/09, With Invitation, Japanese
  80. Head & Neck, Y. Murakami, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, With Invitation, English, Kyoto
  81. Definitive radiotherapy for para aortic lymph node metastasis of cervical squamous cell carcinoma., I. Nishibuchi., K. Wadasaki, Y. Kaneyasu, N. Imano, I. Takahashi, Y. Takeuchi, A. Saito, T. Kimura, Y. Murakami, T. Nishio, Y. Nagata., The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, Without Invitation, English, Kyoto
  82. Role of chemoradiation therapy in multi-modality treatment for resectable esophageal cancer., Y. Murakami, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, With Invitation, Japanese, Kyoto
  83. Current status of the education of Radiation Oncology, Y. Murakami, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, With Invitation, Japanese, Kyoto
  84. Treatment outcomes of chemoradiotherapy for limited-stage small cell lung cancer., I. Takahashi, Y. Takeuchi, I. Nishibuchi, A. Saito, T. Kimura, Y. Murakami, T. Nishio, Y. Nagata, The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, Without Invitation, Japanese, Kyoto
  85. Treatment results of definitive chemo-radiation therapy in patients with cervical esophageal cancer., Y. Takeuchi, Y. Murakami, I. Takahashi, I. Nishibuchi, T. Kimura, A. Saito, T. Nishio, Y. Nagata., The 29th Annual Meeting of the Japanese Sciety for Radiation Oncology, 2016/11/25, Without Invitation, Japanese, Kyoto
  86. Impact of expiratory tumor motion patterns on dose volume histogram in treatment phase selection of respiratory gating radiation therapy for lung cancer, N. Imano, I.Nishibuchi, T. Kimura, T. Nakashima, T. Okumura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  87. Salvage radiotherapy for superficial esophageal cancer after incomplete endoscopic resection, I. Nishibuchi, Y. Murakami, I. Takahashi, Y. Takeuchi, A. Saito, T. Kimura, T. Nishio, Y. Nagata, Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  88. A simplified Three-Isocenter IMRT for craniospinal irradiation to minimize planning and treatment time, I. Takahashi, K. Kashiwado, Y. Takeuchi, I. Nishibuchi, A. Saito, T. Kimura, Y. Murakami, Y. Nagata, Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, English, American Society for Radiation Oncology, Boston, MA, USA
  89. Combined ventilationand perfusion imaging correlates with the dosimetric parameters of radiatoin pneumonitis in radiation therapy planning for lung cancer., T. Kimura, T. Nakashima, A. Saito, Y. Takeuchi, I. Takahashi, I. Nishibuchi, Y. Murakami, T. Nishio, Y. Nagata., Proceedings of the American Society for Radiation Oncology 58th annual meeting(ASTRO), 2016/09/25, Without Invitation, Japanese, American Society for Radiation Oncology, Boston, MA, USA
  90. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy, Y. Murakami, Y. Takeuchi, I. Takahashi, I. Nishibuchi, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Horoshima
  91. Evaluation of adverse events in Atomic Bomb survivors receiving curative-intent radiation therapy from 2005 to 2010, Y. Doi, Murakami, M. Kenjo, T. Kimura, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hirohima
  92. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for ablation therapies., T. Kimura, H. Aikata, I. Takahashi, Y. Takeuchi, I. Nishibuchi, Y. Murakami, K. Awai, K. Chayama, Y. Nagata, GAP (Global Academic Program) related Meeting between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima University and The University of Texas MD Anderson Cancer Center, Hiroshima
  93. Educational lecture IMRT for head and neck cancer, Y. Murakami, Thw 75th annual meeting of Japanese Radiation Society, 2016/04/17, With Invitation, English, Japanese Radiation Society
  94. Clinical features of metachronous cancer in patients with esophageal cancer treated by definitive radiation therapy., Murakami Y., Kawabata H., Takeuchi Y., Nishibuchi I.,Okabe T., Kenjo M., Kimura T., Nagata Y., JASTRO 28th annual meeting, 2015/11/19, Without Invitation, English, JASTRO, Gunma Japan
  95. Incidence and clinical features of metachronous esophageal cancer after definitive radiation therapy for esophageal cancer., Murakami Y, Kawabata H, Takeuchi Y, Doi Y, Okabe T, Kenjo M, Kimura T, Nagata Y., American Society for Radiation Oncology 57th annual meeting(ASTRO), 2015/10/18, Without Invitation, English, American Society for Radiation Oncology, San Antonio,Texas, USA
  96. Preliminary Outcomes of Induction Chemotherapy+VMAT with Concurrent　Chemotherapy for Stage IVA/IVB oro- and Hypopharyngeal Cancer, Yuji Murakami, Tomoki Kimura, Katsumaro Kubo, Hiromi Sakaguchi, Nobuki Imano, Hideo Kawabata, Yoshiko Doi, Masahiro Kenjo, Yasushi Nagata, International congress of Radiation Research(ICRR), 2015/05/25, Without Invitation, English, KYOTO
  97. VMAT for head and neck cancer, Y. Murakami, HICARE/IAEA International Training Course, 2015/01/19, Without Invitation, English, HICARE/IAEA, Hiroshima, Japan
  98. 直腸癌に対する術前化学放射線療法の検討, 川畑秀雄, 村上祐司, 久保克麿, 坂口弘美, 今野伸樹. 土井歓子. 岡部智行. 権丈雅浩. 木村智樹. 永田　靖, 日本放射線腫瘍学会総会, 2014/12, Without Invitation, Japanese
  99. IVA/IVB期中下咽頭癌に対する導入化学療法後化学放射線治療の初期経験, 日本放射線腫瘍学会学術大会, 2014/12, Without Invitation, Japanese, YOKOHAMA
  100. 頭頸部癌に対する導入化学療法後化学放射線療法の検討, 2014/10, Without Invitation, Japanese
  101. Results Of Neoadjuvant Chemoradiotherapy Followed By Surgery For Locally Advanced Esophageal Squamous Cell Carcinom, Y. Murakami, N. Imano, Y. Doi, T. Okabe, M. Kenjo, T. Kimura, J. Hihara, Y. Nagata, The American Society for Radiation Oncology 56th annual meeting(ASTRO), 2014/09/15, Without Invitation, Japanese, SanFrancisco, USA
  102. 上咽頭癌に対する強度変調回転照射の短期成績, 日本医学放射線学会総会, 2014/04, Without Invitation, English, 日本医学放射線学会
  103. 新規治療システムにおける前立腺癌に対するsingle arc VMATの検討, 村上祐司, 中島健雄, 河原大輔 奥村拓朗, 今野伸樹, 勝田　剛, 土井歓子, 岡部智行, 権丈雅浩, 兼安祐子, 木村智樹, 小澤修一, 永田靖, 日本高精度放射線外部照射研究会, 2014/02, Without Invitation, Japanese, 日本高精度放射線外部照射研究会
  104. バリアン新治療システムの使用感～TrueBeam と Eclipse v11.0の強度変調放射線治療における臨床的有用性について～, YUJI MURAKAMI, 2014 Varian Seminar, 2014/02, With Invitation, Japanese, Varian medical
  105. Long-term outcomes of definitive radiotherapy for endometrial cancer., Tani S, Nishibuchi I, Yamamoto Y, Sadatoki T, Miyoshi S, Ishihara S, Katsuta T, Imano N, Doi Y, Murakami Y, The 7th Meeting of the Federation of Asian Organizations for Radiation Oncology(FARO), 2025/11/13, Without Invitation, English, the Federation of Asian Organizations for Radiation Oncology(FARO), Chang Mai, Thailand

Awards

  1. 2023, 2023 Best Paper Awards from volumes 134-135 between July 2022 – June 2023, American College of Oral and Maxillofacial Surgery, American Academy of Oral and Maxillofacial Radiology, American Academy of Oral Medicine, and the American Academy of Oral and Maxillofacial Pathology, Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research for Innovative Cancer Control, 2015/04/01, 2016/03/31
  2. KAKENHI, 2014, 2016
    Permalink
  3. KAKENHI, Development of Functional Image-Guided Radiotherapy Planning inIntensity-Modulated Radiation Therapy (IMRT) for Lung Cancer, 2010, 2012
    Permalink
  4. KAKENHI, Development of a new Stereotactic Body Radiation Therapy (SBRT) and Intensity Modulated Radiation therapy (IMRT) technique using an integrated Image Guide Radiation Therapy (IGRT) system, 2010, 2012
    Permalink
  5. KAKENHI, 2009, 2010
    Permalink
  6. Health and Labour Sciences Research Grants, 2014/05/01, 2015/03/31
  7. KAKENHI, 2015, 2018
  8. Practical Research for Innovative Cancer Control , 2016/04/01, 2017/03/31
  9. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2019/04/01, 2021

Social Activities

Organizing Academic Conferences, etc.

  1. 2025/02, 2025/02
  2. 2022/11, 2022/11
  3. 2024/02, 2024/03
  4. 2023/03, 2023/03
  5. 2021/03, 2021/03
  6. IAEA/RCA Regional Training Course, Faculty member, 2015/01, 2015/01
  7. 2012/07
  8. 2012/07
  9. 2003/04
  10. 2025/02, 2025/02

Other Social Contributions

  1. 2019 Health Science Symposium with Taichung Veterans General Hospital, Current Status of Radiotherapy for Esophageal Squamous Cell Carcinoma in Japan, 2019/07/26, Hiroshima Japan, Lecturer, Meeting or assembly, Researchesrs
  2. HICARE-IAEA seminar, IMRT for Localized Prostate Cancer, HICARE-IAEA, 2019/02/18, Hiroshima Japan, Lecturer, Seminar or workshop, Researchesrs
  3. Preceptorship in HNC, Current status of Multidisciplinary Team for head and neck cancer patients, 2018/11/23, Lecturer, Seminar or workshop, Researchesrs

History as Peer Reviews of Academic Papers

  1. 2025, Japanese Journal of Radiology, Others, Reviewer, 2
  2. 2025, Journal of Radiation Research, Others, Reviewer, 1
  3. 2025, Esophagus, Others, Reviewer, 1
  4. 2025, International Journal of Clinical Oncology, Others, Reviewer, 3
  5. 2024, Journal of Radiation Research, Others, 1
  6. 2024, International Journal of Clinical Oncology, Others, reviewer, 2
  7. 2022, International journal of clinical oncology, Others, reviewer, 1
  8. 2022, biomeditics, Others, reviewer, 1
  9. 2022, Esophagus, Others, reviewer, 2
  10. 2022, Journal of radiation research, Others, reviewer, 3
  11. 2020, JOrunal of radiation research, Others, reviewer, 2
  12. 2020, Esophagus, Others, Reviewer, 1
  13. 2020, Japanese journal of clinical oncology, Others, Reviewer, 1
  14. 2016, The journal of radiation research, Others, reviewer, 8
  15. 2016, Radiation Oncology, Others, reviewer, 1
  16. 2015, The Journal of Radiation Research, Others, Reviewer, 2
  17. 2014, The Journal of Radiation Research, Others, Reviewer, 3